SUPPLEMENTAL AND EXTENDED MATERIAL AND METHODS

Cell growth and colony formation assays
Transduced melanoma cells were seeded in a 6-well plate in duplicates and grown at 37°C, 5% CO2. At indicated days Resazurin reagent (Promega) was added to the cell culture for 30 minutes after which the media was removed and transferred to the black 96-well tissue culture plate for fluorescence readings. Fluorescence and absorbance were subsequently measured using a plate reader (Biotech Synergy HT). Fluorescence values were normalized to the background readings collected from the wells that had no growing cells but contained growth culture media and Resazurin reagent. For adherent colony formation assays, 103 cells were seeded in 6-well plates and cultured at 37°C, 5% CO2. Numbers of colonies were counted every 3 days for 2 weeks under light microscope. Cell morphological images were taken by EVOS XL Core Imaging System (Thermo Fisher, CA, USA). At the end of the assay, the plates were washed with PBS, fixed with MeOH and stained with Crystal violet.
In vivo tumor growth assay
Tumor cells were suspended in 35 μL of Matrigel solution, then mixed with 65 μL of 2% HBSS prior to injection. Cells were injected into 2 flanks of the NOD. Cg-Prkdc scid Il2rgtm1Wjl/SzJ (NSG) mice (100 cells per injection, n=10). Tumor related symptoms were monitored every three days within each population. Tumors were measured periodically using external calipers and their size was determined using modified ellipsoid formula (v = π/6 · 1.63√(L x W) 3 ). At the end of the monitoring period mice were euthanized, tumor and internal organs were surgically removed and embedded in Tissue-Plus O.C.T. compounds (Fisher Healthcare, CA). Cyro-sectioning was done at -20°C with Leica CM3050 system (Leica, Germany). Sections were stained with hematoxylin and eosin (H&E). Images were taken by Nikon TI-E fluorescent microscope.
Analysis of cancer patient survival based on FZD3 expression levels
Gene expression and clinical data were analyzed for previously described cohorts of melanoma patients: GSE8401 (n = 83) and GSE46517 (n = 84). Mean FZD3 mRNA expression was analyzed using GEO2R software (https://www.ncbi.nlm.nih.gov/geo/geo2r/). Clinical and gene expression data linked to individual patient survival follow up was downloaded and analyzed using KM Plotter. Briefly, patients were stratified into high and low groups based on median FZD3 expression and Kaplan-Meier analysis was performed for overall survival. p values were determined using a log-rank test, confidence interval (CI) was set at 95, hazard ratio (HR) was determined using a univariant Cox regression model, values are shown for the relationship of outcomes to dichotomous expression of FZD3.
qRT-PCR
Total RNA was extracted from cancer cells using Trizol reagent (Life Technologies). The mRNAs were reverse transcribed into cDNAs using Verso cDNA synthesis kits (Life Technologies), followed by real-time PCR using KAPA SYBR® FAST qPCR Master Mix (2X) Kit (Sigma-Aldrich, MO, USA). Gene-specific primer sets are summarized in Supplemental Table 2 . Values were normalized against 18S using the ΔΔCT method 1,2 . Data are shown as means and standard deviations (SD) with unpaired Student's t-test with p value < 0.05.
Western blot
Cells were lysed with RIPA buffer and protein concentration was determined by BCA assay (Pierce). Protein lysates were separated by SDS-PAGE, transferred to nitrocellulose membranes (Bio-Rad), blocked with 5% milk/TBS, and probed with antibodies in 4°C overnight. The following antibodies were used for Western blot: rabbit anti-GAPDH, (Cell Signaling Technology, Danvers, MA, USA), mouse anti-CDK1, rabbit anti-CDK2, mouse anti-CDK4 (Santa Cruz, Dallas, TX, USA), rabbit anti-cyclin D1, rabbit anti-cyclin E2, rabbit anti-cyclin B1, anti-β-catenin (Cell Signaling Technology, Danvers, MA, USA). All primary antibodies were used at 1:1000 dilution. Membranes were washed three times for 5 min and incubated with a 1:1000 dilution of horseradish peroxidase-conjugated anti-rabbit or anti-mouse (Sigma-Aldrich, MO, USA) antibodies. Blots were washed three times and developed with the ECL system (Pierce) according to the manufacturer's protocols.
Cell immunostaining and analysis
Cells were grown in 4-well Lab-Tek chamber slides and fixed in 4% paraformaldehyde. The slides were incubated with primary antibodies FZD3 (1:200) (MAB1001 R&D system, MN, USA), β-catenin (1:100) (#8480 Cell Signaling), following staining with the secondary antibody Alexa Fluor 594 (1:400) or Alexa Fluor 488 (1:400), (Life technologies, CA). Nuclei were visualized using DAPI reagent. Following immunostaining, immunofluorescent images were taken using a Nikon TI-E fluorescent microscope and a minimum of 10 fields were analyzed for the quantification of positive target protein staining over total DAPI positive cells using ImageJ.
Dual luciferase assay
Target cells were transduced with shFZD3 or shSC lentiviruses, followed by transient transfection of TOPFLASH and FOPFLASH plasmids (2 μg) (Addgene) with renilla luciferase plasmid (0.5 μg) using ViaFect Transfection reagent (Promega, Madison, WI, USA). 3 days after infection and transfection, cells were counted and lysed in passive luciferase lysis buffer (Promega). Luciferase assay was performed with the Dual Luciferase Reporter assay system (Promega). Luminescence was measured using Sirius Luminometer V3.2. Renilla luciferase reporter was used to normalize for transfection efficiency.
